Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Molecular docking studies of bioactive compounds from the leaves of Epiphyllum oxypetalum against Treponema pallidum, Zika virus and Liver Cirrhosis

Abhishek Biswal R,Jayashree P,Kanna Mirunaalini,Vivek Pazhamalai.




Abstract
Cited by 3 Articles

The Epiphyllum oxypetalum is a unique plant that belongs to a cactaceae family. Traditionally this plant mainly cures sexually transmitted diseases, liver infection, anti-viral disease. The molecular docking analysis was done against virulent bacterial and viral enzymes. The protein responsible for bacterial and viral disease were studied and retrieved from Protein Data Bank. The bioactive compounds of Epiphyllum oxypetalum were docked against Treponema pallidum, liver cirrhosis and zika virus. The result obtained with better binding interactions against Treponema pallidum was Megastigmatrienone with -5.02Kcal/mol followed by liver cirrhosis was Megastigmatrienone with -4.58Kcal/mol and against zika virus was Testerone cypionate with -7.84Kcal/mol. Thus, the molecular docking interactions shows better potential of inhibition against virulent enzymes and the bioactive compounds of Epiphyllum oxypetalum leaves which could be used as lead for treating the diseases such as Syphilis, Liver cirrhosis, Zika virus.

Key words: PDB [protein data bank], Treponema pallidum, PDHK2 [Pyruvate dehydrogenase kinase 2], Molecular docking






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.